TGF-beta and Common gamma-Chain Cytokine Crosstalk in T Cell Regulation

T 细胞调节中的 TGF-β 和常见伽马链细胞因子串扰

基本信息

  • 批准号:
    7893474
  • 负责人:
  • 金额:
    $ 42.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A functional adaptive immune system depends on a diverse and self-tolerant population of T lymphocytes that are generated in the thymus and maintained in the peripheral lymphoid organs. Recent studies have defined the cytokine transforming growth factor-beta (TGF-beta) as a critical regulator of thymic T cell development as well as a crucial player in peripheral T cell homeostasis, tolerance to self-antigens, and T cell differentiation during the immune responses. The long-term objective of this proposal is to elucidate the mechanisms by which TGF-beta regulates T cells. T cell defects observed in mice with T cell-specific deletion of Tgfbr2 gene are associated with abnormal expression of receptors for cytokines of the common gamma-chain receptor family including interleukin 7 (IL-7), IL-2, and IL-15. To determine the function of compromised CD127 (IL-7 receptor alpha chain) expression in TGF-beta receptor II-deficient thymocytes and naive T cells, a strain of CD127 transgenic mice will be used. To determine the role of anomalous CD122 (IL-2/15 receptor beta chain) expression in TGF-beta receptor II-deficient effector T cells, a strain of IL-15-deficient mice will be utilized. These mice will be crossed with T cell-specific TGF-beta receptor II-deficient mice, and the correction of T cell defects will be determined. Defects of TGF-beta receptor II-deficient T cells are additionally associated with abnormal expression of Gfi-1, T-bet, and Eomes, transcription factors that regulate CD127 and CD122 expression. The functions of Gfi-1, T-bet, and Eomes in control of CD127 and CD122 expression and TGF- beta receptor II-deficient T cell activity will be addressed using mice that are deficient in these transcription factors. Finally, the role of TGF-beta-activated Smad proteins in Gfi-1, T-bet, and Eomes repression in T cells will be studied. Successful completion of the projects outlined in this proposal will generate mechanistic insights into the crosstalk between TGF-beta and the common gamma-chain cytokines in T cell regulation. PUBLIC HEALTH RELEVANCE: T lymphocytes play a key role in immune-related diseases such as infection, autoimmune diseases, transplant rejection, and cancer. It has been established that the secreted molecule TGF-beta is a critical regulator of T cell differentiation and function. Experiments proposed here will define how TGF-beta controls T cells.
描述(由申请人提供):功能性适应性免疫系统依赖于胸腺中产生并在外周血淋巴器官中维持的多样化和自我耐受的T淋巴细胞群。最近的研究将细胞因子转化生长因子- β (tgf - β)定义为胸腺T细胞发育的关键调节因子,以及免疫应答过程中外周T细胞稳态、对自身抗原的耐受性和T细胞分化的关键参与者。这项建议的长期目标是阐明tgf - β调节T细胞的机制。Tgfbr2基因在T细胞特异性缺失小鼠中观察到的T细胞缺陷与常见γ链受体家族细胞因子受体的异常表达有关,包括白细胞介素7 (IL-7)、IL-2和IL-15。为了确定tgf - β受体ii缺陷胸腺细胞和幼稚T细胞中CD127 (IL-7受体α链)表达受损的功能,将使用一株CD127转基因小鼠。为了确定CD122 (IL-2/15受体β链)异常表达在tgf - β受体ii缺陷效应T细胞中的作用,将利用一株il -15缺陷小鼠。这些小鼠将与T细胞特异性tgf - β受体ii缺陷小鼠杂交,并确定T细胞缺陷的纠正。tgf - β受体ii缺陷T细胞的缺陷还与调节CD127和CD122表达的转录因子Gfi-1、T-bet和Eomes的异常表达有关。Gfi-1、T-bet和Eomes在控制CD127和CD122表达以及TGF- β受体ii缺陷T细胞活性方面的功能将通过缺乏这些转录因子的小鼠进行研究。最后,将研究tgf - β激活的Smad蛋白在T细胞中Gfi-1、T-bet和Eomes抑制中的作用。本提案中概述的项目的成功完成将产生对T细胞调节中tgf - β和常见γ链细胞因子之间串扰的机制见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ming Li其他文献

Ming Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ming Li', 18)}}的其他基金

Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer
癌症中 CD8 T 细胞耗竭的抗原呈递细胞控制
  • 批准号:
    10659843
  • 财政年份:
    2023
  • 资助金额:
    $ 42.75万
  • 项目类别:
Understanding vascular aging-related dementia through medin signaling
通过 medin 信号传导了解血管老化相关痴呆
  • 批准号:
    10901026
  • 财政年份:
    2023
  • 资助金额:
    $ 42.75万
  • 项目类别:
Random Field Methods for integrative genomic analysis and high-dimensional risk prediction of congenital heart defects
用于先天性心脏病综合基因组分析和高维风险预测的随机场方法
  • 批准号:
    10905156
  • 财政年份:
    2023
  • 资助金额:
    $ 42.75万
  • 项目类别:
Characterization of TMEM251 that causes a new type of severe lysosome storage disease
引起新型严重溶酶体贮积病的 TMEM251 的表征
  • 批准号:
    10502880
  • 财政年份:
    2022
  • 资助金额:
    $ 42.75万
  • 项目类别:
Discovering the Origin of Vascular Aging Amyloid Protein Medin
发现血管老化淀粉样蛋白的起源
  • 批准号:
    10351895
  • 财政年份:
    2022
  • 资助金额:
    $ 42.75万
  • 项目类别:
Characterization of TMEM251 that causes a new type of severe lysosome storage disease
引起新型严重溶酶体贮积病的 TMEM251 的表征
  • 批准号:
    10705155
  • 财政年份:
    2022
  • 资助金额:
    $ 42.75万
  • 项目类别:
Random Field Modelling of genetic and epigenetic association underlying congenital heart defects in the presence of disease heterogeneity
存在疾病异质性的情况下先天性心脏缺陷的遗​​传和表观遗传关联的随机场建模
  • 批准号:
    10405321
  • 财政年份:
    2021
  • 资助金额:
    $ 42.75万
  • 项目类别:
Ontogeny and Function of Tumor-Resident Innate Lymphocytes and Innate-Like T Cells
肿瘤固有淋巴细胞和先天样 T 细胞的个体发育和功能
  • 批准号:
    10197862
  • 财政年份:
    2020
  • 资助金额:
    $ 42.75万
  • 项目类别:
Ontogeny and Function of Tumor-Resident Innate Lymphocytes and Innate-Like T Cells
肿瘤固有淋巴细胞和先天样 T 细胞的个体发育和功能
  • 批准号:
    10415158
  • 财政年份:
    2020
  • 资助金额:
    $ 42.75万
  • 项目类别:
Ontogeny and Function of Tumor-Resident Innate Lymphocytes and Innate-Like T Cells
肿瘤固有淋巴细胞和先天样 T 细胞的个体发育和功能
  • 批准号:
    10610432
  • 财政年份:
    2020
  • 资助金额:
    $ 42.75万
  • 项目类别:

相似海外基金

Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens
针对 1 型糖尿病自身抗原的工程化 TCR-Treg 细胞疗法
  • 批准号:
    10764143
  • 财政年份:
    2023
  • 资助金额:
    $ 42.75万
  • 项目类别:
Study of identification for autoantigens in a mouse model of pituitary dysfunction induced by CTLA-4 or PD-1 blockade
CTLA-4或PD-1阻断诱导的垂体功能障碍小鼠模型中自身抗原的鉴定研究
  • 批准号:
    22K08648
  • 财政年份:
    2022
  • 资助金额:
    $ 42.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens
针对 1 型糖尿病自身抗原的工程化 TCR-Treg 细胞疗法
  • 批准号:
    10545634
  • 财政年份:
    2022
  • 资助金额:
    $ 42.75万
  • 项目类别:
identification of autoantigens of autoimmune pancreatitis
自身免疫性胰腺炎自身抗原的鉴定
  • 批准号:
    21H02901
  • 财政年份:
    2021
  • 资助金额:
    $ 42.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Genetic Basis of Variable Expression of Glycan Xeno-Autoantigens by Cattle
牛聚糖异种自身抗原变异表达的遗传基础
  • 批准号:
    DP200103734
  • 财政年份:
    2020
  • 资助金额:
    $ 42.75万
  • 项目类别:
    Discovery Projects
The study to identify novel pathogenesis and autoantigens in patients with membranous nephropathy
确定膜性肾病患者新发病机制和自身抗原的研究
  • 批准号:
    19K08694
  • 财政年份:
    2019
  • 资助金额:
    $ 42.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Project 3-Proteomic Analysis of Explanted Livers with characterization of Autoantigens
项目 3 - 外植肝脏的蛋白质组学分析及自身抗原的表征
  • 批准号:
    10356015
  • 财政年份:
    2019
  • 资助金额:
    $ 42.75万
  • 项目类别:
Project 3-Proteomic Analysis of Explanted Livers with characterization of Autoantigens
项目 3 - 外植肝脏的蛋白质组学分析及自身抗原的表征
  • 批准号:
    10560561
  • 财政年份:
    2019
  • 资助金额:
    $ 42.75万
  • 项目类别:
Project 3-Proteomic Analysis of Explanted Livers with characterization of Autoantigens
项目 3 - 外植肝脏的蛋白质组学分析及自身抗原的表征
  • 批准号:
    10093988
  • 财政年份:
    2019
  • 资助金额:
    $ 42.75万
  • 项目类别:
Identification of autoantigens presented by specific HLA class I alleles in aplastic anemia
再生障碍性贫血中特定 HLA I 类等位基因呈现的自身抗原的鉴定
  • 批准号:
    19H03686
  • 财政年份:
    2019
  • 资助金额:
    $ 42.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了